glp 1 and longevity GLP-1s: The world's first drug? The Evolution of GLP-1 Users
Description
In 2023, Humphrey and Lawrence emphasized the importance for plastic surgeons to recognize these potential effects, counsel patients before initiating therapy, and consider both surgical and non-surgical interventions to mitigate facial volume loss, sagging, and premature aging [86]
Notoriously, both GIPR agonists and antagonists lead to weight loss mainly when co-administrated with GLP-1 agonists or analogues (Killion et al
Patients should seek medical advice for persistent gastrointestinal symptoms, severe abdominal pain, dehydration, hypoglycaemia, or vision changes
Neurobiol Aging (2012) 33(2):26576
